Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Riboflavin/UVA Cross-linked Corneas for Boston KPro
NCT01582880Phase 2Completed
- Start
- Mar 2012
- Primary completion
- Mar 2014
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of riboflavin in pitted keratolysis (PK). Started Mar 2012; status: completed.
02
Drugs
riboflavin
03
Conditions
pitted keratolysis (PK)
Beyond the preview
Go deeper on NCT01582880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01582880.